[-] Show simple item record

dc.contributor.advisorAhsan, Humeraen_US
dc.contributor.authorBahador, Farshad Michael
dc.contributor.authorKim, Thomas
dc.date.issued2010-11eng
dc.description.abstractReversible Posterior Encephalopathy Syndrome (PRES) is characterized by confusion, drowsiness, vomiting, seizure and visual loss. This neurologic syndrome was first described in 1996. Almost half of those patients had undergone bone marrow or solid organ transplant, and were under treatment with Cyclosporin or Tacrolimus. During the past decade its association with other co-morbidities including hypertensive encephalopathy, pre-eclamspisa/eclampsia, autoimmune diseases, post-streptococcal glomerulonephritis and Henoch-Schonlein has been shown.en_US
dc.identifier.urihttp://hdl.handle.net/10355/9161
dc.relation.ispartof2010 Health Sciences Research Day (MU)en_US
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. Health Sciences Research Day.
dc.subjectaltered mental statusen_US
dc.subjectbrain edemaen_US
dc.subject.lcshSepticemia
dc.subject.lcshCerebral edema
dc.subject.lcshDelirium
dc.titleAtypical presentation of posterior reversible encephalopathy syndrome in a patient with sepsisen_US
dc.typeOtheren_US


Files in this item

[PDF]
[PDF]

This item appears in the following Collection(s)

[-] Show simple item record